Close Menu

NEW YORK (GenomeWeb) – Researchers in the Netherlands have developed a diagnostic test to detect lung cancer by examining tumor RNA absorbed by circulating platelets called thrombocytes.

Published in Cancer Cell earlier today, the study investigated the potential and origin of spliced RNA profiles from tumor-educated platelets, or TEPs, for the noninvasive detection of early- and late-stage non-small cell lung cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.